With Donanemab on the Cusp of Approval, Proper Alzheimer’s Diagnosis Is Urgent

By /

Accurately diagnosing Alzheimer’s disease pathologies is becoming increasingly important, but the U.S. is facing imaging resource constraints.

Scroll to Top